We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$40.8M
Cap. Flow
+$16.7M
Cap. Flow %
4.41%
Top 10 Hldgs %
63.44%
Holding
142
New
7
Increased
51
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$10.1M
2
SONY icon
Sony
SONY
+$3.72M
3
ADM icon
Archer Daniels Midland
ADM
+$1.22M
4
PFE icon
Pfizer
PFE
+$716K
5
AAPL icon
Apple
AAPL
+$532K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$617K
2
ABBV icon
AbbVie
ABBV
+$444K
3
MRK icon
Merck
MRK
+$409K
4
ECL icon
Ecolab
ECL
+$212K
5
A icon
Agilent Technologies
A
+$202K

Sector Composition

Rank Sector Weight
1 Technology 11.25%
2 Healthcare 10.5%
3 Consumer Staples 5.1%
4 Communication Services 3.11%
5 Materials 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
76
Mondelez International
MDLZ
$79.9B
$513K 0.14%
7,324
+464
+7% +$33.9K
ZBH icon
77
Zimmer Biomet
ZBH
$18.4B
$495K 0.13%
3,753
-126
-3% -$15.7K
PGR icon
78
Progressive
PGR
$125B
$492K 0.13%
2,380
-236
-9% -$43.8K
AVGO icon
79
Broadcom
AVGO
$2.04T
$486K 0.13%
3,670
-470
-11% -$58.2K
WFC icon
80
Wells Fargo
WFC
$264B
$482K 0.13%
8,317
-876
-10% -$45.8K
CAH icon
81
Cardinal Health
CAH
$55.4B
$482K 0.13%
4,304
+278
+7% +$30K
ABT icon
82
Abbott
ABT
$187B
$472K 0.12%
4,155
-249
-6% -$28.5K
BIIB icon
83
Biogen
BIIB
$30.7B
$472K 0.12%
2,187
+247
+13% +$57.8K
TGT icon
84
Target
TGT
$68B
$471K 0.12%
2,658
-163
-6% -$24.8K
CL icon
85
Colgate-Palmolive
CL
$74.4B
$468K 0.12%
5,198
-93
-2% -$7.88K
INGR icon
86
Ingredion
INGR
$6.58B
$461K 0.12%
3,944
-64
-2% -$7.21K
ALL icon
87
Allstate
ALL
$67.5B
$442K 0.12%
2,552
-300
-11% -$47.4K
CNC icon
88
Centene
CNC
$32.5B
$440K 0.12%
5,607
+9
+0.2% +$695
COR icon
89
Cencora
COR
$61.2B
$424K 0.11%
1,745
-158
-8% -$36.3K
BAC icon
90
Bank of America
BAC
$442B
$424K 0.11%
11,173
-506
-4% -$17.4K
HUM icon
91
Humana
HUM
$46.2B
$410K 0.11%
1,183
+384
+48% +$146K
IBM icon
92
IBM
IBM
$224B
$410K 0.11%
2,147
-269
-11% -$49.1K
K
93
DELISTED
Kellanova
K
$394K 0.1%
6,869
+208
+3% +$11.5K
CHD icon
94
Church & Dwight Co
CHD
$24.5B
$378K 0.1%
3,628
+81
+2% +$8.1K
ISRG icon
95
Intuitive Surgical
ISRG
$134B
$378K 0.1%
946
-130
-12% -$49.1K
MRSH
96
Marsh
MRSH
$91.5B
$376K 0.1%
1,825
+119
+7% +$23.7K
AIG icon
97
American International
AIG
$41.3B
$371K 0.1%
4,747
+20
+0.4% +$1.43K
V icon
98
Visa
V
$677B
$370K 0.1%
1,325
-44
-3% -$12.1K
EW icon
99
Edwards Lifesciences
EW
$51.7B
$368K 0.1%
3,850
-763
-17% -$64.1K
DMC
100
Del Monte Corp
DMC
$1.45B
$367K 0.1%
14,164
+855
+6% +$21.2K
2 3
4
5 6

Similar funds

MWM
Momentous Wealth Management Vancouver, Washington $175M AUM 14.91% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return
CC
Converium Capital Montreal $175M AUM
BW
Basepoint Wealth Cedar Rapids, Iowa $175M AUM 43.04% 1-Year Est. Return
DWA
Delos Wealth Advisors Dallas, Texas $175M AUM 19.35% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Humankind Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Humankind Investments held 142 positions worth $378M, up 12% from $337M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Humankind Investments deployed $16.7M of net new capital in Q1 2024, opening 7 new positions and adding to 51 existing holdings. Its largest new stake was Sony: 202,195 shares worth $3.47M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Eli Lilly, an estimated $617K trimmed.

  • Humankind Investments's largest Q1 2024 buy was Sony: 202,195 shares worth $3.47M.
  • Humankind Investments added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2024, an estimated $10.1M increase.
  • Humankind Investments's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $617K.
  • Humankind Investments fully exited Agilent Technologies in Q1 2024, selling an estimated $202K.
  • Humankind Investments's ten largest holdings make up 63% of its $378M portfolio in Q1 2024.
  • Humankind Investments opened 7 new positions and closed 3 in Q1 2024.
  • Humankind Investments's portfolio value rose 12% quarter-over-quarter to $378M.

Based on Humankind Investments's 13F filing for Q1 2024, filed 8 May 2024.